PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...

Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...

Gore & Associates announced FDA approval of the Gore Viabahn Fortegra venous stent—previously known as the Gore Viafor ...

Ceribell, Inc. announced that the FDA has granted Breakthrough Device designation for its large vessel occlusion (LVO) stroke de ...

Galaxy Therapeutics announced it has completed enrollment in the SEAL IT pivotal trial evaluating the company’s saccular ...

CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...

The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery dise ...

December 3, 2025—Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeGraft Plus, which features a new 77/78-mm length. On November ...

November 19, 2025—Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair (BEVAR), expanding Bentley’s ...

November 17, 2025—Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the company by an affiliate of GTCR LLC. In May 2024, the company ...

November 3, 2025—Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascular Interventional Advances conference. Additionally, the ...

October 22, 2025—Techsomed Ltd., an Israel-based developer of medical artificial intelligence–powered software for image-guided therapy, announced a pilot collaboration with Medtronic. The ...